People: Theragenics Corp (TGX)
TGX on New York Consolidated
2.02USD
17 May 2013
2.02USD
17 May 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$2.02
$2.02
Open
$2.02
$2.02
Day's High
$2.03
$2.03
Day's Low
$2.01
$2.01
Volume
97,991
97,991
Avg. Vol
79,377
79,377
52-wk High
$2.15
$2.15
52-wk Low
$1.32
$1.32
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
M. Christine Jacobs |
61 | 2007 | Chairman of the Board, President, Chief Executive Officer |
Francis Tarallo |
52 | 2005 | Chief Financial Officer, Treasurer |
Joseph Plante |
47 | 2009 | President of NeedleTech Products |
Janet Zeman |
56 | 2008 | President of CP Medical |
Bruce Smith |
59 | 2005 | Executive Vice President - Strategy and Business Development, Secretary |
C. Russell Small |
52 | 2008 | Executive Vice President |
John Herndon |
71 | 1994 | Director |
Kathleen Dahlberg |
60 | 2008 | Independent Director |
K. Wyatt Engwall |
64 | 2008 | Independent Director |
Charles Moody |
55 | 2007 | Independent Director |
Peter Saunders |
70 | 1989 | Independent Director |
Lisa Rassel |
Primary IR Officer |
Biographies
| Name | Description |
|---|---|
M. Christine Jacobs |
Ms. M. Christine Jacobs is Chairman of the Board, President, Chief Executive Officer of Theragenics Corp. Since 1992, Ms. Jacobs has been President and Chief Operating Officer of the Company, and in August 1993, Ms. Jacobs was promoted to the position of Chief Executive Officer while retaining the position of President. In 1997 Ms. Jacobs was elected Co-Chairman, and in 1998 she was elected Chairman. She served as Chairman from 1998 to 2005, and from 2007 to present. Ms. Jacobs is also a member of the Board of Directors of McKesson Corporation, a healthcare products and services provider and a NYSE-listed company. Ms. Jacobs serves on McKesson’s Compensation and Corporate Governance Committees. In 2011 Ms. Jacobs was appointed to the SEC Advisory Committee on Small and Emerging Companies, where she currently serves as co-chair. The committee advises the SEC on rules, regulations and policies pertaining to small and emerging companies in the areas of capital raising, trading in securities and reporting and corporate governance. |
Francis Tarallo |
Mr. Francis J. Tarallo is Chief Financial Officer, Treasurer of Theragenics Corp., since August 8, 2005. He serves as President of the company brachytherapy business since July 2007. He joined Theragenics in June 1998 as Director of Finance, and served as General Manager, Oak Ridge, from January 2001 to August 2005. Mr. Tarallo is a Certified Public Accountant. |
Joseph Plante |
Mr. Joseph Plante is President of NeedleTech Products is the subsidiary of Theragenics Corp., since October 2009. Since December 2009, Mr. Plante’s responsibilities have also included management of the company Galt Medical subsidiary. He has over 20 years experience in the medical device field and has acquired and run his own manufacturing business. Mr. Plante was the General Manager at HydroCision, Inc., a spine medical device manufacturing start up, from 2002 to 2008 where he founded and grew the spine business unit to a multi-million dollar franchise while helping to sell licensing agreements and raise venture capital money. From 1990 to 2002 Mr. Plante held various product development management positions at Covidien and Haemonetics Corp. |
Janet Zeman |
Ms. Janet E. Zeman is President of CP Medical of Theragenics Corp., since September 12, 2008. From March 2008 until September 2008, Ms. Zeman served as the General Manager of CP Medical. From August 2003 to March 2008 Ms. Zeman served as Vice President of New Medical Products for Theragenics, and in 2005 she assumed additional responsibilities as Vice President of Government Affairs. Ms. Zeman joined Theragenics in 1996 as Director of Regulatory Affairs. |
Bruce Smith |
Mr. Bruce W. Smith is Executive Vice President - Strategy and Business Development, Secretary of Theragenics Corp. Mr. Smith has been the company Executive Vice-President for Strategy and Business Development since August 2002, Secretary since May 2005 and an Executive Vice-President since 1998. Mr. Smith joined Theragenics in 1987 and served as the company Chief Financial Officer, Secretary and Treasurer from 1989 to August 2002. Mr. Smith serves as a director of the Georgia Bio, a 501(c)(3) organization and serves on the Medical Device Subcommittee of the Metro Atlanta Chamber of Commerce’s BioScience Council. |
C. Russell Small |
Mr. C. Russell Small is Executive Vice President of Theragenics Inc., since July 2008. He leads the company surgical products sales group. Mr. Small was a co-founder of NeedleTech Products in 1988 and served as Vice President of NeedleTech Products from 2000 to 2009. Prior to NeedleTech, Mr. Small worked for five years in medical device product development for various device companies. |
John Herndon |
Mr. John V. Herndon is Director of Theragenics Corp. Mr. Herndon joined the Company in April 1987 as Executive Vice President and in July 1989, was appointed President, Chief Executive Officer and Chairman of the Board of Directors of the Company. In August 1993, Mr. Herndon relinquished his role as Chief Executive Officer while retaining his position as Chairman of the Board of Directors of the Company. Mr. Herndon stepped down as Chairman of the Board in December 1994 and currently serves as a Director and Advisor to the Chief Executive Officer. |
Kathleen Dahlberg |
Ms. Kathleen A. Dahlberg is Independent Director of Theragenics Corp. Ms. Dahlberg has been the Chief Executive Officer of 2Unify LLC, a communications company, since 2006. Ms. Dahlberg has been the President and Chief Executive Officer of Open Vision Partners and a business consultant on the application of new technologies for business improvement and process change since September 2001. Ms. Dahlberg has held Vice-Presidential positions with BP Amoco, Viacom International, McDonalds Corporation, Grand Metropolitan plc and American Broadcasting. Additionally, she has been President of Galileo Group International Services. Ms. Dahlberg is also a Director of P.H. Glatfelter Company, a New York Stock Exchange listed company. Glatfelter is a manufacturer of specialty papers and engineered products. Ms. Dahlberg serves on the Glatfelter’s Compensation Committee and also serves on its Nominating and Corporate Governance Committee. In addition, Ms. Dahlberg is a regular author and speaker on topics of business technology, risk management, benefit realization and governance for profitability. |
K. Wyatt Engwall |
Mr. K. Wyatt Engwall is Independent Director of Theragenics Corrp. Mr. Engwall served as Chief Financial Officer of Morrison Management Specialists from June 1996 until his retirement in January 2005. Morrison’s was listed on the NYSE until purchased by Compass Group LLC in 2001. Prior to 1996 at Morrison’s, Mr. Engwall served in various capacities at Morrison Management Specialists. Mr. Engwall is a Certified Public Accountant. |
Charles Moody |
Mr. Charles David Moody, Jr., is Independent Director of Theragenics Corp. Mr. Moody is President and Chief Executive Officer of C. D. Moody Construction Company, a commercial construction firm which Mr. Moody founded in 1988. Since 2000, Mr. Moody has also served as a director of Citizens Bancshares Corporation, a bank holding company traded on the OTC Bulletin Board, where he is a member of the Loan Committee, a member of the Executive Committee and Chairman of the Asset and Liability Committee. Mr. Moody’s current role as CEO of C.D. Moody Construction Company provides the company Board with critical insight into organizational and operational management as well as financial matters. |
Peter Saunders |
Mr. Peter A.A. Saunders is Independent Director of Theragenics Corp. Prior to his retirement in 1999, Mr. Saunders was Owner/Chairman of PASS Consultants from 1988 to 1997, a marketing and business consultancy company based in the United Kingdom. From 1992 to 1994 he served as managing director of United Artists Communications (London-U.K.) Ltd. and from 1972 to 1988 Mr. Saunders held various senior executive and managing directorship positions with Allders Department Stores in the U.K. From 1993 to 1998 Mr. Saunders was a non-executive business director of Mayday University Hospital, a 700-bed hospital in London. |
Lisa Rassel |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
M. Christine Jacobs |
1,414,490 |
Francis Tarallo |
735,236 |
Joseph Plante |
-- |
Janet Zeman |
411,319 |
Bruce Smith |
679,176 |
C. Russell Small |
-- |
John Herndon |
-- |
Kathleen Dahlberg |
-- |
K. Wyatt Engwall |
-- |
Charles Moody |
-- |
Peter Saunders |
-- |
Lisa Rassel |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
M. Christine Jacobs |
840,105 | 214,659 |
Francis Tarallo |
38,200 | 0 |
Joseph Plante |
0 | 0 |
Janet Zeman |
0 | 0 |
Bruce Smith |
186,000 | 71,000 |
C. Russell Small |
0 | 0 |
John Herndon |
0 | 0 |
Kathleen Dahlberg |
0 | 0 |
K. Wyatt Engwall |
0 | 0 |
Charles Moody |
0 | 0 |
Peter Saunders |
0 | 0 |
Lisa Rassel |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
ZEMAN JANET |
128,000 | $0.00 |
SMITH BRUCE W |
151,100 | $0.00 |
JACOBS MARY CHRISTINE |
276,400 | $0.00 |
SMALL C RUSSELL |
128,000 | $0.00 |
PLANTE JOSEPH |
128,000 | $0.00 |
TARALLO FRANCIS J |
158,800 | $0.00 |
HERNDON JOHN V |
15,000 | $0.00 |
DAHLBERG KATHLEEN A |
15,000 | $0.00 |
SAUNDERS PETER A A |
15,000 | $0.00 |
ENGWALL K WYATT |
15,000 | $0.00 |
MOODY CHARLES DAVID JR |
15,000 | $0.00 |
MOODY CHARLES DAVID JR |
15,000 | $0.00 |
SAUNDERS PETER A A |
15,000 | $0.00 |
DAHLBERG KATHLEEN A |
15,000 | $0.00 |
HERNDON JOHN V |
15,000 | $0.00 |
ENGWALL K WYATT |
15,000 | $0.00 |
SMALL C RUSSELL |
87,250 | $0.00 |
JACOBS MARY CHRISTINE |
164,800 | $0.00 |
ZEMAN JANET |
87,250 | $0.00 |
PLANTE JOSEPH |
87,250 | $0.00 |
SMITH BRUCE W |
101,800 | $0.00 |
TARALLO FRANCIS J |
106,650 | $0.00 |
MOODY CHARLES DAVID JR |
15,000 | $0.00 |
ENGWALL K WYATT |
15,000 | $0.00 |
SAUNDERS PETER A A |
15,000 | $0.00 |

